Abstract
Introduction: In the perioperative setting, there is still a high incidence of adverse cardiac events due to sudden coronary plaque rupture or oxygen supply-demand imbalance. beta-Blockers play an important role in preventing these cardiac events. Discussion, however, remains on the side effects accompanying this therapy. Areas covered: The evidence for perioperative use of beta-blockers is summarized in this review in terms of risk reduction, perioperative safety and current clinical use. Furthermore, data on pharmacokinetics, pharmacodynamics and pharmacogenetics are presented. Expert opinion: In perioperative care, beta-blockers are recommended and can be given safely when started early in a low dose, titrated to heart rate. In the future, there could be a place for added perioperative short-acting beta-blockers to further optimize heart rate control.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 545-558 |
Number of pages | 14 |
Journal | Expert Opinion on Drug Safety |
Volume | 10 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2011 |
Research programs
- EMC COEUR-09